Coeptis Therapeutics Holdings Ratios (2021-2025) | COEP

Ratios Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin 28.18%77.50%80.98%
EBT Margin -5,440.95%-2,159.94%-1,220.84%
EBIT Margin -6,452.56%-2,252.94%-1,043.22%
EBITDA Margin -6,452.56%-2,252.94%-1,043.22%
Operating Margin -6,452.56%-2,252.94%-1,043.22%
Net Margin -5,440.95%-2,159.94%-1,220.84%
FCF Margin -3,763.35%-1,194.30%-906.42%
Efficiency
Assets Average 76.52M76.40M41.56M41.37M54.55M33.21M20.61M6.93M6.55M7.16M5.87M6.98M8.93M11.18M12.82M13.19M
Equity Average 5.00M-0.28M-1.60M2.34M2.20M4.40M5.60M2.65M1.40M1.93M1.35M-0.16M-0.73M2.34M4.42M5.67M7.27M9.00M
Invested Capital 5.00M5.00M-5.56M2.35M2.34M2.06M7.08M4.45M0.85M1.96M1.89M0.81M-1.14M-0.31M4.98M4.91M8.10M7.08M10.92M
Asset Utilization Ratio 0.010.020.04
Leverage & Solvency
Interest Coverage Ratio -281.54-153.74-98.70-22.43-208.13-87.43-399.05-243.35-14.58-42.81-42.06-27.50-56.75-66.70-39.56
Debt to Equity 0.700.100.050.030.180.080.080.18-0.130.030.310.110.020.01
Debt Ratio 0.240.010.010.020.030.020.020.030.020.020.130.060.010.01
Equity Ratio 0.070.07-0.070.350.030.060.200.560.140.270.260.18-0.120.560.430.550.580.77
Times Interest Earned -281.54-153.74-98.70-22.43-208.13-87.43-399.05-243.35-14.58-42.81-42.06-27.50-56.75-66.70-39.56
Valuation
Enterprise Value -0.77M-0.64M-0.58M-2.18M-2.34M-2.38M-7.37M-3.79M-2.11M-3.24M-1.41M-1.47M-1.03M-1.56M-0.98M-0.05M-3.28M-2.00M-4.78M
Return Ratios
Return on Sales -54.41%-21.60%-12.21%
Return on Capital Employed -1.00%-1.85%-5.53%-5.38%-4.30%-7.47%-6.68%-2.28%-2.02%-1.54%-1.26%
Return on Assets 0.00%-0.46%-0.53%-1.04%-1.82%-3.80%-3.02%-2.86%-3.62%-2.34%-1.22%-1.01%-0.98%-1.04%
Return on Equity 0.09%-8.18%-13.18%-7.87%-6.71%-9.94%-14.07%-10.62%-15.71%99.86%22.26%-4.97%-2.46%-1.99%-1.73%-1.52%